Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the first minimally-invasive heart procedure using its new real-time 3D ...
Global introduction 1 of innovative imaging tool designed to support the treatment of cardiovascular diseases, including structural heart disease repairs, without the need for open heart surgery World ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of its VeriSight Pro 3D Intracardiac Echocardiography (ICE) ...
Philips’ 3D intracardiac echocardiography catheter is ready for its close-up—its extreme, in vivo close-up, that is. A little less than a year after securing 510(k) clearance from the FDA, the ...
Philips, a global leader in health technology, announced the launch of ELiTE, an innovative offline training programme for echocardiography in collaboration with Narayana Institute of Cardiac Sciences ...
Health technology company Royal Philips announced the release of Transcend Plus, its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems. Transcend Plus features FDA-cleared 2D- and 3D-image ...
Philips announces first patient treated with its new real-time 3D intracardiac echocardiography catheter – VeriSight Pro GlobeNewswire July 01, 2021 FDA 510k-cleared real-time 3D intracardiac ...
FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart disease and electrophysiology procedures Reduced need for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback